摘要
目的探讨雾化吸入重组人干扰素α1b(IFN-α1b)对重症手足口病(HFMD)患儿血清白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、干扰素-γ(IFN-γ)、C-反应蛋白(CRP)水平的影响。方法选取2015年6月至2016年10月西安市儿童医院收治的重症手足口病患儿100例,随机分为IFN-α1b plus HFMD实验组(50例)及HFMD对照组(50例),HFMD对照组给予常规治疗,IFN-α1b plus HFMD实验组在常规治疗基础上连续雾化吸入IFN-α1b治疗5d,采用酶联免疫吸附试验(ELISA)法检测治疗后两组患儿血清IL-6、TNF-α、IFN-γ及CRP水平。结果治疗第1天,两组患儿血清IL-6、TNF-α、IFN-γ和CRP浓度水平相近,差异均无统计学意义(t值分别为2.542、3.916、1.237、4.132,均P>0.05),治疗第3天、第5天,IFN-α1b plus HFMD实验组患儿血清IL-6、TNF-α、IFN-γ和CRP浓度水平明显下降,低于HFMD对照组,差异均有统计学意义(第3天:t值分别为11.023、11.867、10.745、15.264;第5天:t值分别为14.568、13.248、11.458、14.852;均P<0.05)。结论重组人IFN-α1b能够通过抗病毒作用和抑制细胞因子作用减轻炎症反应,从而减缓重症HFMD的发展。
Objective To study the effects of aerosolized recombinant interferonα1 b(IFN-α1 b)on serum interleukin 6(IL-6),tumor necrosis factorα(TNF-α),interferonγ(INF-γ)and C-reactive protein(CRP)levels in cases with severe hand-foot and mouth disease(HFMD).Methods One hundred cases of severe HFMD were selected from June 2015 to October 2016 in Xi'an Children's Hospital,and they were randomly divided into IFN-α1 bplus HFMD experimental group and HFMD control group.Conventional treatment was provided for the control group,and continuous aerosolized IFN-α1 bfor 5 days was additionally provided for the experimental group.Serum IL-6,TNF-α,INF-γand CRP levels were detected by ELISA.Results The levels of serum IL-6,TNF-α,INF-γand CRP levels were similar in two groups after 1-day treatment,and the difference was not significant(t value was2.542,3.916,1.237,4.132,P 0.05).At 3 and 5 day after treatment,serum IL-6,TNF-α,INF-γand CRP levels declined remarkably in the experimental group,and they were lower than those in the control group with statistical significance(t value was11.023,11.867,10.745 and 15.264 at 3 day,t value was 14.568,13.248,11.458 and 14.852 at 5 day).Conclusion The inflammatory reaction is relieved through antiviral effect and inhibitory effect with IFN-α1 b,delaying the development of severe HFMD.
作者
张瑜
袁娟
谢燕
符佳
张玉凤
邓慧玲
ZHANG Yu;YUAN Juan;XIE Yan;FU Jia;ZHANG Yu-feng;DENG Hui-ling(Xi'an Children'Hospital,Shaanxi Xi'an 710003,China)
出处
《中国妇幼健康研究》
2018年第9期1080-1083,共4页
Chinese Journal of Woman and Child Health Research
基金
陕西省科技统筹重点产业创新链工程计划资助项目(2016KTZDSF02-04)
西安市科学技术局医疗卫生研究资助项目(2016052SF/YX08)
关键词
手足口病
重组人干扰素Α1B
白介素-6
肿瘤坏死因子-α
干扰素-Γ
C-反应蛋白
hand
foot and mouth disease (HFMD)
recombinant interferon α1b(IFN-α1b)
serum interleukin 6 (IL-6)
tumornecrosis factor α (TNF-α)
interferon γ (INF-γ)
C-reactive protein(CRP)